Drug Type Interferons, Biosimilar |
Synonyms Peginterferon alfa-2a (Dong-A Pharma), DA-3021 |
Target |
Action agonists |
Mechanism IFNAR agonists(Interferon alpha/beta receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hepatitis B | Phase 1 | - | - | |
| Hepatitis C | Phase 1 | - | - |






